Historical shareholding details of BlackRock Health Sciences Opps Port holdings in Regeneron Pharmaceuticals, Inc. (REGN)

Monthly changes of BlackRock Health Sciences Opps Port shareholding in Regeneron Pharmaceuticals, Inc. over the previous months

Month Name Total no. shares held Percent Holding
Jul 31, 2025 Blackrock Health Sciences Opps Port 110,379 0.10%
Jun 30, 2025 Blackrock Health Sciences Opps Port 144,734 0.14%
May 31, 2025 Blackrock Health Sciences Opps Port 144,734 0.13%
Apr 30, 2025 Blackrock Health Sciences Opps Port 144,734 0.13%
Mar 31, 2025 Blackrock Health Sciences Opps Port 144,734 0.13%
Feb 28, 2025 Blackrock Health Sciences Opps Port 96,829 0.09%
Jan 31, 2025 Blackrock Health Sciences Opps Port 96,829 0.09%
Dec 31, 2024 Blackrock Health Sciences Opps Port 101,367 0.09%
Nov 30, 2024 Blackrock Health Sciences Opps Port 101,367 0.09%
Oct 31, 2024 Blackrock Health Sciences Opps Port 101,367 0.09%
Sep 30, 2024 Blackrock Health Sciences Opps Port 146,132 0.13%
Aug 31, 2024 Blackrock Health Sciences Opps Port 146,132 0.13%
Jul 31, 2024 Blackrock Health Sciences Opps Port 132,462 0.12%
Jun 30, 2024 Blackrock Health Sciences Opps Port 132,462 0.12%
May 31, 2024 Blackrock Health Sciences Opps Port 132,462 0.12%
Apr 30, 2024 Blackrock Health Sciences Opps Port 132,462 0.12%
Mar 31, 2024 Blackrock Health Sciences Opps Port 132,462 0.12%
Feb 29, 2024 Blackrock Health Sciences Opps Port 132,462 0.12%
Jan 31, 2024 Blackrock Health Sciences Opps Port 132,462 0.12%
Dec 31, 2023 Blackrock Health Sciences Opps Port 132,462 0.12%
Nov 30, 2023 Blackrock Health Sciences Opps Port 132,462 0.12%
Oct 31, 2023 Blackrock Health Sciences Opps Port 132,462 0.12%
Sep 30, 2023 Blackrock Health Sciences Opps Port 132,462 0.12%
Aug 31, 2023 Blackrock Health Sciences Opps Port 138,337 0.13%
Jul 31, 2023 Blackrock Health Sciences Opps Port 138,337 0.13%
Jun 30, 2023 Blackrock Health Sciences Opps Port 156,832 0.14%
May 31, 2023 Blackrock Health Sciences Opps Port 265,262 0.24%
Apr 30, 2023 Blackrock Health Sciences Opps Port 265,262 0.24%

View all ownership details of Regeneron Pharmaceuticals, Inc.